NeuroVive’s NV556 Inhibits Liver Tumor Growth in Mice, Study Indicates
NV556 inhibited tumor growth in mice with a liver disease known as non-alcoholic steatohepatitis, or NASH, according to a study by its maker, NeuroVive Pharmaceutical AB.
News
‘Good Cholesterol’ Therapy CER-209 Enters Phase 1 Trial for NAFLD and NASH
Cerenis Therapeutics has initiated a Phase 1 clinical trial of CER-209 for the treatment of non-alcoholic steatohepatitis (NASH) and non-alcoholic fatty liver disease (NAFLD).
Ocera’s Therapy Candidate OCR-002 Prevented Cirrhosis Progression in NAFLD Animal Models
The latest preclinical results of Ocera Therapeutics’ ammonia scavenger OCR-002 showed that it can reduce fibrosis progression in animal models of non-alcoholic fatty liver…
Albireo Hosts NYC Breakfast to Discuss A4250 Therapy for Pediatric Liver Diseases
Boston-based Albireo Pharma hosted an April 13 breakfast presentation in New York that featured an overview of the company’s clinical programs as well as a talk by…
Galectin Plans to Present Data from Phase 2 NASH Cirrhosis Trial by Year’s End
Galectin Therapeutics’s lead drug GR-MD-02 may be a promising therapeutic approach to treat fibrosis in fatty liver disease — or non-alcoholic steatohepatitis (NASH) — based on results from…
Bozitinib Suppresses Liver Tumor Growth in Lab Setting, Study Shows
Bozitinib (CBT-101) suppresses the growth of human liver tumors in a laboratory environment, according to its maker, CBT Pharmaceuticals. The oral therapy works by…
Conatus Discusses Its Liver Disease Therapy Emricasan at Two New York Events
Conatus Pharmaceuticals updated participants at two New York medical conferences this month on  its efforts to develop emricasan, which has been shown to improve manifestations…
Statins May Be Option for Treating Chronic Liver Disease, Study Suggests
A new review suggests that statins — used primarily to manage cholesterol — may be effective in treating liver inflammation and chronic liver disease. Statins are…
Bowel Disease Patients Who Are Older and Have Had Disease Longer Are at Higher Risk of Liver Disease
Thirteen percent of patients with inflammatory bowel disease (IBD) also had non-alcoholic fatty liver disease (NAFLD), according to a Texas study. The overlap occurred despite…
New Approach to Drug Discovery Finds Veterinary Pill Helps Mice Fight Liver Cancer
A relative of a veterinary de-worming pill, in combination with the standard treatment Nexavar (sorafenib), was found to halt the growth of hepatocellular cancer (HCC) in laboratory…
